Brief: Sema4 Reports Q3 Financial Results And New Strategic Direction
Nov 14 (Reuters) - Sema4 Holdings Corp SMFR.O :
* SEMA4 REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND NEW
STRATEGIC DIRECTION
* SEMA4 HOLDINGS CORP - TOTAL REVENUE FOR Q3 OF 2022 WAS
$83.2
MILLION COMPARED TO $43.2 MILLION IN Q3 OF 2021
* SEMA4 HOLDINGS CORP - MAINTAINING PREVIOUSLY ISSUED FULL
YEAR
AND SECOND HALF 2022 REPORTED REVENUE GUIDANCE
* SEMA4 HOLDINGS CORP - QTRLY DILUTED NET LOSS INCOME PER
SHARE,
CLASS A COMMON STOCK OF $0.20
Source text for Eikon: ID:nGNX6SlXpk
Further company coverage: SMFR.O
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth